Old Web
English
Sign In
Acemap
>
authorDetail
>
Silvia L. Locatelli
Silvia L. Locatelli
Programmed cell death
PI3K/AKT/mTOR pathway
Biology
Immunology
Cell growth
3
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest.
2016
Leukemia
Silvia L. Locatelli
Giuseppa Careddu
Giorgio Inghirami
Luca Castagna
Peter Sportelli
Armando Santoro
Carmelo Carlo-Stella
Show All
Source
Cite
Save
Citations (11)
The PI3K/ERK Dual Inhibitor AEZS-136 Induces ROS-Dependent Necroptotic Cell Death and Exerts Potent Antitumor Effects In NOD/SCID Mice With Hodgkin Lymphoma Cell Line Xenografts
2013
Blood
Silvia L. Locatelli
Giuliano Giuseppe Stirparo
Silvia Tartari
Elena Saba
Luca Rubino
Ercole Brusamolino
Luca Castagna
Armando Santoro
Carmelo Carlo-Stella
Show All
Source
Cite
Save
Citations (1)
The PI3K-δ Inhibitor TGR-1202 In Combination With Brentuximab Vedotin (SGN-35) Synergistically Induces G2/M Phase Arrest and Cell Death Via Inhibition Of Tubulin Polymerization In Hodgkin Lymphoma Cell Lines
2013
Blood
Silvia L. Locatelli
Silvia Tartari
Luca Rubino
Ercole Brusamolino
Luca Castagna
Peter Sportelli
Armando Santoro
Carmelo Carlo-Stella
Show All
Source
Cite
Save
Citations (1)
1